Upgrade to SI Premium - Free Trial

Citi downgrades Moderna to Sell, sets $80 price target

September 30, 2026 5:01 AM
(Updated - September 30, 2026 5:03 AM EDT)

Citi analyst Geoff Meacham downgraded Moderna (NASDAQ: MRNA) from Neutral to ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Downgrades Hot Downgrades